Claire has more than 15 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual and Contract Research Organisations. Having taken a range of therapeutic products through clinical Phases 1 to 3, she thrives on translating innovative technologies into healthcare products and shaping technical and organisational strategies. Exceptional communication is key in everything she does. Whether it is writing investor communications, technical and regulatory reports, Trade Press articles or talking at international conferences, Claire’s focus is on conveying a message in an impactful manner to the target audience.
Claire holds a degree in Biochemistry from the University of St. Andrews and a PhD from the School of Pharmacy, University of Nottingham. Claire also holds Honorary Senior Lecturer positions with University of Birmingham and University College London. She is Chief Scientist of the Academy of Pharmaceutical Sciences and plays a leading role in the Royal Pharmaceutical Society’s professional recognition programme.
Photo credit: Nadia Attura, Royal Pharmaceutical Society
Over the years, Trevor has followed a career path which has taken in a huge range of science, technology and communications along the way. Most recently he led the gold mining industry’s market development efforts in technology – this involved everything from television appearances on CNN and SABC to synthesising new catalysts in Silicon Valley (he’s still a scientist at heart). He developed a multi-channel communications campaign which highlighted the important role mining companies play in the fight against diseases such as malaria in Africa and beyond. Prior to this, Trevor spent a few years at GlaxoSmithKline working on projects across the entire development portfolio.
Trevor holds a degree in Chemistry from University of Kent, a PhD in Nanotechnology from University of Nottingham and a business degree from University College London. He is an accomplished communicator, regularly presenting at international conferences and producing written collateral for audiences of all types. He is absolutely passionate about two things in his working life – accelerating new technologies to market, and helping companies communicate their science in an impactful manner.